S-2326 : Still Just a Bill

New Opportunities for Value that Extend Lives Act of 2019 or the NOVEL Act of 2019

This bill establishes a process for expediting the assignment of Healthcare Common Procedure Coding System (HCPCS) codes to medical products that have been designated as a breakthrough product or regenerative advanced therapy by the Food and Drug Administration; it also establishes a process for determining coverage under Medicare of such breakthrough products that have been assigned HCPCS codes.

Action Timeline

Action DateTypeTextSource
2019-07-30IntroReferralRead twice and referred to the Committee on Finance.Senate
2019-07-30IntroReferralIntroduced in SenateLibrary of Congress

Policy Area :

Health
See Subjects
  • Drug safety, medical device, and laboratory regulation
  • Drug therapy
  • Government information and archives
  • Health care costs and insurance
  • Health care coverage and access
  • Health technology, devices, supplies
  • Manufacturing
  • Medicare
  • Public participation and lobbying

Related Bills

See Related Bills